Cargando…

Panacea, a semantic-enabled drug recommendations discovery framework

BACKGROUND: Personalized drug prescription can be benefited from the use of intelligent information management and sharing. International standard classifications and terminologies have been developed in order to provide unique and unambiguous information representation. Such standards can be used a...

Descripción completa

Detalles Bibliográficos
Autores principales: Doulaverakis, Charalampos, Nikolaidis, George, Kleontas, Athanasios, Kompatsiaris, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975719/
https://www.ncbi.nlm.nih.gov/pubmed/24602515
http://dx.doi.org/10.1186/2041-1480-5-13
_version_ 1782310180647600128
author Doulaverakis, Charalampos
Nikolaidis, George
Kleontas, Athanasios
Kompatsiaris, Ioannis
author_facet Doulaverakis, Charalampos
Nikolaidis, George
Kleontas, Athanasios
Kompatsiaris, Ioannis
author_sort Doulaverakis, Charalampos
collection PubMed
description BACKGROUND: Personalized drug prescription can be benefited from the use of intelligent information management and sharing. International standard classifications and terminologies have been developed in order to provide unique and unambiguous information representation. Such standards can be used as the basis of automated decision support systems for providing drug-drug and drug-disease interaction discovery. Additionally, Semantic Web technologies have been proposed in earlier works, in order to support such systems. RESULTS: The paper presents Panacea, a semantic framework capable of offering drug-drug and drug-diseases interaction discovery. For enabling this kind of service, medical information and terminology had to be translated to ontological terms and be appropriately coupled with medical knowledge of the field. International standard classifications and terminologies, provide the backbone of the common representation of medical data while the medical knowledge of drug interactions is represented by a rule base which makes use of the aforementioned standards. Representation is based on a lightweight ontology. A layered reasoning approach is implemented where at the first layer ontological inference is used in order to discover underlying knowledge, while at the second layer a two-step rule selection strategy is followed resulting in a computationally efficient reasoning approach. Details of the system architecture are presented while also giving an outline of the difficulties that had to be overcome. CONCLUSIONS: Panacea is evaluated both in terms of quality of recommendations against real clinical data and performance. The quality recommendation gave useful insights regarding requirements for real world deployment and revealed several parameters that affected the recommendation results. Performance-wise, Panacea is compared to a previous published work by the authors, a service for drug recommendations named GalenOWL, and presents their differences in modeling and approach to the problem, while also pinpointing the advantages of Panacea. Overall, the paper presents a framework for providing an efficient drug recommendations service where Semantic Web technologies are coupled with traditional business rule engines.
format Online
Article
Text
id pubmed-3975719
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39757192014-04-17 Panacea, a semantic-enabled drug recommendations discovery framework Doulaverakis, Charalampos Nikolaidis, George Kleontas, Athanasios Kompatsiaris, Ioannis J Biomed Semantics Research BACKGROUND: Personalized drug prescription can be benefited from the use of intelligent information management and sharing. International standard classifications and terminologies have been developed in order to provide unique and unambiguous information representation. Such standards can be used as the basis of automated decision support systems for providing drug-drug and drug-disease interaction discovery. Additionally, Semantic Web technologies have been proposed in earlier works, in order to support such systems. RESULTS: The paper presents Panacea, a semantic framework capable of offering drug-drug and drug-diseases interaction discovery. For enabling this kind of service, medical information and terminology had to be translated to ontological terms and be appropriately coupled with medical knowledge of the field. International standard classifications and terminologies, provide the backbone of the common representation of medical data while the medical knowledge of drug interactions is represented by a rule base which makes use of the aforementioned standards. Representation is based on a lightweight ontology. A layered reasoning approach is implemented where at the first layer ontological inference is used in order to discover underlying knowledge, while at the second layer a two-step rule selection strategy is followed resulting in a computationally efficient reasoning approach. Details of the system architecture are presented while also giving an outline of the difficulties that had to be overcome. CONCLUSIONS: Panacea is evaluated both in terms of quality of recommendations against real clinical data and performance. The quality recommendation gave useful insights regarding requirements for real world deployment and revealed several parameters that affected the recommendation results. Performance-wise, Panacea is compared to a previous published work by the authors, a service for drug recommendations named GalenOWL, and presents their differences in modeling and approach to the problem, while also pinpointing the advantages of Panacea. Overall, the paper presents a framework for providing an efficient drug recommendations service where Semantic Web technologies are coupled with traditional business rule engines. BioMed Central 2014-03-06 /pmc/articles/PMC3975719/ /pubmed/24602515 http://dx.doi.org/10.1186/2041-1480-5-13 Text en Copyright © 2014 Doulaverakis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Doulaverakis, Charalampos
Nikolaidis, George
Kleontas, Athanasios
Kompatsiaris, Ioannis
Panacea, a semantic-enabled drug recommendations discovery framework
title Panacea, a semantic-enabled drug recommendations discovery framework
title_full Panacea, a semantic-enabled drug recommendations discovery framework
title_fullStr Panacea, a semantic-enabled drug recommendations discovery framework
title_full_unstemmed Panacea, a semantic-enabled drug recommendations discovery framework
title_short Panacea, a semantic-enabled drug recommendations discovery framework
title_sort panacea, a semantic-enabled drug recommendations discovery framework
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975719/
https://www.ncbi.nlm.nih.gov/pubmed/24602515
http://dx.doi.org/10.1186/2041-1480-5-13
work_keys_str_mv AT doulaverakischaralampos panaceaasemanticenableddrugrecommendationsdiscoveryframework
AT nikolaidisgeorge panaceaasemanticenableddrugrecommendationsdiscoveryframework
AT kleontasathanasios panaceaasemanticenableddrugrecommendationsdiscoveryframework
AT kompatsiarisioannis panaceaasemanticenableddrugrecommendationsdiscoveryframework